20 May 2013
Keywords: roche, files, emea, market, zenapax, filed, approval
Article | 10 September 1997
- Roche has filed for approval with the European Medicines EvaluationAgency to market Zenapax (dacliximab), for the prevention of rejection
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 September 1997
11 September 1997
17 May 2013
© 2013 thepharmaletter.com